Tanja Obradovic, Vice President, Medical and Scientific Strategy, Oncology at Novotech, shared on LinkedIn:
“ESMO 2026 was outstanding opportunity for Novotech team to get immersed into new reports across tumor indications and have productive scientific exchange with Biotech community.”
